Risky behaviour on drug classification.
D026683:Advisory Committees; D006213:Hallucinogens / Q000009:adverse effects / Q000145:classification*; D006801:Humans; D007880:Legislation, Drug; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects / Q000145:classification*; D019966:Substance-Related Disorders / Q000401:mortality; D006113:United Kingdom
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine